संपर्क करें
कम्पनी के बारे में
The pharmaceutical companies are eager to obtain maximum information from fewer clinical trials at early stage. This enables quicker “go/no-go” decision for the development strategy of a given compound. The landscape of early clinical development has dramatically changed over the last years. The amount of Phase 1 studies in healthy volunteers has decreased, being replaced by Phase 1b/2a studies in patients.
DE
अनजान
अनजान
सत्यापित कंपनी नहीं
व्यापार पारदर्शिता
- कंपनी की जानकारी सत्यापित नहीं की
- समीक्षा के लिए अपने ग्राहकों से पूछें
- नकारात्मक समीक्षाओं का जवाब नहीं दिया